ERBB4 and intrahepatic cholangiocarcinoma: Another study showed that ERBB3 and ERBB4 were upregulated in 12.3% (8/65) and 63.1% (41/65) of patients with ICC and 11.8% (13/110) and 56.4% (62/110) of those with ECC, respectively.